JPRN-UMIN000027832已完成1 期
Is 5-alpha reductase inhibitor capable to alter the natural history of slightly enlarged prostate? a prospective multi center study - Five-alpha reductase inhibitor for slightly enlarged prostate with LUTS
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 27
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 50years-old 至 ot applicable（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- •use of drugs affecting prostate volume such as antiandrogenic agent
研究者
相似试验
Unknown
2 期
Finasteride, Dutasteride and Insulin ActionHealthy VolunteersNCT01923090University of Birmingham12
已完成
不适用
Demonstrating the Clinical and Economic Benefit of 5 Alpha Reductase Inhibitor Adherence in Benign Prostatic HyperplasiaProstatic HyperplasiaNCT01334723GlaxoSmithKline35,032
已完成
不适用
Treatment of Refractory Urinary Retention Secondary to Benign Prostatic Hyperplasia (BPH) With Dual Five Alpha Reductase Inhibition Combined With an Alpha BlockerUrinary RetentionBenign Prostatic HyperplasiaNCT00680680Franklin D. Gaylis, MD Inc.20
已完成
2 期
5-Alpha Reductase and Anabolic Effects of TestosteroneMale HypogonadismMuscle AtrophySarcopeniaBenign Prostate HypertrophyNCT00475501VA Office of Research and Development60
尚未招募
2 期
The effect of alpha-adrenergic blocking drugs on reducing the excitatory symptoms of ureteral stent placementIRCT20201006048950N3Arak University of Medical Sciences60